D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 23,051 387 World Ranking 13322 National Ranking 1220

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

His primary areas of study are Physical therapy, Rheumatoid arthritis, Internal medicine, Rheumatology and MEDLINE. John R. Kirwan has included themes like Osteoarthritis, Clinical trial, Patient satisfaction and Psychological intervention in his Physical therapy study. His research in Rheumatoid arthritis intersects with topics in Inflammation, Severity of illness, Health assessment and Arthritis.

His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo and Surgery. His Rheumatology research incorporates themes from Alternative medicine, Necrosis, Family medicine and Health professionals. He interconnects Rheumatism and Evidence-based practice in the investigation of issues within MEDLINE.

His most cited work include:

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials (993 citations)
  • Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III (634 citations)
  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 (484 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Rheumatoid arthritis, Physical therapy, Internal medicine, Rheumatology and Clinical trial. His Rheumatoid arthritis study incorporates themes from Prednisolone, Glucocorticoid, Disease and Arthritis. His work carried out in the field of Physical therapy brings together such families of science as Osteoarthritis, Alternative medicine, Patient satisfaction, MEDLINE and Randomized controlled trial.

His Osteoarthritis study combines topics in areas such as Knee Joint and Radiography. His work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine. John R. Kirwan regularly ties together related areas like Severity of illness in his Clinical trial studies.

He most often published in these fields:

  • Rheumatoid arthritis (45.93%)
  • Physical therapy (40.74%)
  • Internal medicine (34.57%)

What were the highlights of his more recent work (between 2012-2020)?

  • Physical therapy (40.74%)
  • Rheumatoid arthritis (45.93%)
  • Internal medicine (34.57%)

In recent papers he was focusing on the following fields of study:

John R. Kirwan mostly deals with Physical therapy, Rheumatoid arthritis, Internal medicine, Rheumatology and Randomized controlled trial. The various areas that he examines in his Physical therapy study include Psychological intervention, Self-management, Clinical trial, Arthritis and Intervention. His study in Clinical trial is interdisciplinary in nature, drawing from both Visual analogue scale, Context, Family medicine and Scope.

The Rheumatoid arthritis study combines topics in areas such as Alternative medicine, Disease, Coping, Clinical psychology and Prednisone. His Internal medicine study integrates concerns from other disciplines, such as Immunology and Outcomes research. His work in Randomized controlled trial tackles topics such as Mood which are related to areas like Feeling.

Between 2012 and 2020, his most popular works were:

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 (484 citations)
  • EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases (158 citations)
  • Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) (118 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His main research concerns Physical therapy, Internal medicine, Rheumatology, Outcome and Medical education. His Physical therapy research is multidisciplinary, incorporating elements of Clinical trial, Quality of life, Systematic review, Rheumatoid arthritis and Severity of illness. His Rheumatoid arthritis research includes elements of Rating scale, Disease, Coping and Outcomes research.

His study in Morning and Prednisone is carried out as part of his studies in Internal medicine. John R. Kirwan combines subjects such as Osteoarthritis, Context, Randomized controlled trial, Intention-to-treat analysis and Visual analogue scale with his study of Rheumatology. His studies in Medical education integrate themes in fields like Alternative medicine, Patient participation and Moderation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)

1673 Citations

Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III

Nicholas Bellamy;John Kirwan;Maarten Boers;Peter Brooks.
The Journal of Rheumatology (1997)

996 Citations

Determinants of disability in osteoarthritis of the knee.

T. E. M. Mcalindon;C. Cooper;J. R. Kirwan;P. A. Dieppe.
Annals of the Rheumatic Diseases (1993)

737 Citations

Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

Maarten Boers;John R. Kirwan;George Wells;Dorcas Beaton.
Journal of Clinical Epidemiology (2014)

733 Citations

STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS

J. R. Kirwan;Jane S. Reeback.
Rheumatology (1986)

708 Citations

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

J A P Da Silva;J W G Jacobs;J R Kirwan;M Boers.
Annals of the Rheumatic Diseases (2006)

582 Citations

Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy.

Paul Dieppe;Janet Cushnaghan;Philip Young;John Kirwan.
Annals of the Rheumatic Diseases (1993)

568 Citations

Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

F. Buttgereit;J.A. da Silva;M. Boers;G.R. Burmester.
Annals of the Rheumatic Diseases (2002)

541 Citations

EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

J. N. Hoes;J. W. G. Jacobs;M. Boers;D. Boumpas.
Annals of the Rheumatic Diseases (2007)

507 Citations

Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

John R Kirwan;Johannes Wj Bijlsma;Maarten Boers;Beverley Shea.
Cochrane Database of Systematic Reviews (2007)

459 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John R. Kirwan

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 136

Maarten Boers

Maarten Boers

Vrije Universiteit Amsterdam

Publications: 127

Peter Tugwell

Peter Tugwell

University of Ottawa

Publications: 121

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 121

Paul Emery

Paul Emery

University of Leeds

Publications: 119

George D. Kitas

George D. Kitas

Dudley Group NHS Foundation Trust

Publications: 108

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 105

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 97

Robin Christensen

Robin Christensen

University of Southern Denmark

Publications: 97

Deborah P. M. Symmons

Deborah P. M. Symmons

University of Manchester

Publications: 96

Vibeke Strand

Vibeke Strand

Stanford University

Publications: 96

David T. Felson

David T. Felson

Boston University

Publications: 87

Frank Buttgereit

Frank Buttgereit

Charité - University Medicine Berlin

Publications: 83

Johannes W. J. Bijlsma

Johannes W. J. Bijlsma

Utrecht University

Publications: 82

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 77

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 75

Trending Scientists

Hans-Joachim Wunderlich

Hans-Joachim Wunderlich

University of Stuttgart

Erwin Lutwak

Erwin Lutwak

Courant Institute of Mathematical Sciences

William O'Brien

William O'Brien

Carleton University

Andrew F. G. Quest

Andrew F. G. Quest

University of Chile

Åke Lernmark

Åke Lernmark

Lund University

Hauke Lilie

Hauke Lilie

Martin Luther University Halle-Wittenberg

Lut Van Laer

Lut Van Laer

University of Antwerp

Andrew J. Davison

Andrew J. Davison

University of Glasgow

Teresa Zelante

Teresa Zelante

University of Perugia

Shuanggen Jin

Shuanggen Jin

Chinese Academy of Sciences

Liwu Zeng

Liwu Zeng

Peking University

Jonathan Cebon

Jonathan Cebon

La Trobe University

Giovanni Passalacqua

Giovanni Passalacqua

University of Genoa

Andrew Hyland

Andrew Hyland

Roswell Park Cancer Institute

Matthew J. Ellis

Matthew J. Ellis

Baylor College of Medicine

Iris Zalaudek

Iris Zalaudek

University of Trieste

Something went wrong. Please try again later.